Denying access to long-acting injectable treatment for HIV: an open letter
Lancet HIV
.
2024 Dec;11(12):e802.
doi: 10.1016/S2352-3018(24)00305-9.
Authors
Thokozile Malaba
1
,
Jessica Henn
2
,
Catriona Waitt
3
,
Landon Myer
1
,
Saye Khoo
3
,
Miriam Taegtmeyer
4
,
Catherine Orrell
5
;
DolPHIN3 consortium
Affiliations
1
University of Cape Town, Cape Town, South Africa.
2
Desmond Tutu HIV Centre, University of Cape Town, Cape Town 7700, South Africa.
3
University of Liverpool, Liverpool, UK.
4
Liverpool School of Tropical Medicine, Liverpool, UK.
5
Desmond Tutu HIV Centre, University of Cape Town, Cape Town 7700, South Africa. Electronic address: catherine.orrell@hiv-research.org.za.
PMID:
39632049
DOI:
10.1016/S2352-3018(24)00305-9
No abstract available
Publication types
Letter